Obesity in short stem total hip arthroplasty using a minimally invasive supine anterolateral approach-a risk factor for short-term complications?


Journal

International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431

Informations de publication

Date de publication:
11 2021
Historique:
received: 11 03 2021
accepted: 11 05 2021
pubmed: 1 7 2021
medline: 12 11 2021
entrez: 30 6 2021
Statut: ppublish

Résumé

Obesity is associated with increased risk for surgical complications in total hip arthroplasty (THA). The impact of obesity on short-term complication in minimally invasive (MIS) anterolateral approach is not well known. Therefore, this study was conducted to evaluate the early complications within the first 90 days after THA using a MIS anterolateral approach with a short-curved stem stratified by Body Mass Index (BMI). A single centre consecutive series of 1052 hips in 982 patients (index surgery 2014-2019) with a short-curved stem and press fit cup implanted using a MIS anterolateral approach in supine position were screened for inclusion. Inclusion criteria were defined as end-stage primary osteoarthritis of the hip. Eventually, 878 implantations in 808 patients were included and stratified by body mass index (BMI). Peri-operative complications, within the first 90 days after surgery, were retrospectively evaluated. Severely obese patients (BMI ≥ 35 kg/m The risk for early PJI and overall surgical complications in MIS anterolateral approach is significantly increased in severely and morbidly obese patients. This leads to a significantly higher risk for revision surgery after index surgery within the first 90 days. A BMI above 35 kg/m

Identifiants

pubmed: 34191091
doi: 10.1007/s00264-021-05079-1
pii: 10.1007/s00264-021-05079-1
pmc: PMC8560722
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2833-2841

Informations de copyright

© 2021. The Author(s).

Références

Bone Joint J. 2019 Jun;101-B(6):646-651
pubmed: 31154834
JAMA. 2003 Jan 1;289(1):76-9
pubmed: 12503980
J Arthroplasty. 2019 May;34(5):947-953
pubmed: 30765229
J Arthroplasty. 2018 Oct;33(10):3281-3287
pubmed: 29631859
J Arthroplasty. 2012 Mar;27(3):397-401
pubmed: 21676578
Orthopedics. 2002 Oct;25(10):1031-43
pubmed: 12401009
J Diabetes Complications. 2014 Nov-Dec;28(6):831-5
pubmed: 25104238
Acta Orthop. 2019 Jun;90(3):220-225
pubmed: 30931664
J Bone Joint Surg Br. 2011 Sep;93(9):1178-82
pubmed: 21911527
J Arthroplasty. 2018 Mar;33(3):856-864
pubmed: 29089223
J Arthroplasty. 2020 Sep;35(9):2652-2657
pubmed: 32389402
J Arthroplasty. 2015 Sep;30(9 Suppl):42-6
pubmed: 26117070
J Bone Joint Surg Am. 2013 May 1;95(9):775-82
pubmed: 23636183
BMC Geriatr. 2019 Apr 17;19(1):112
pubmed: 30995903
J Bone Joint Surg Am. 2012 Oct 17;94(20):1839-44
pubmed: 23079875
Clin Orthop Relat Res. 2004 Dec;(429):248-55
pubmed: 15577495
Int Orthop. 2001;25(1):22-4
pubmed: 11374262
J Bone Joint Surg Am. 2016 Feb 3;98(3):169-79
pubmed: 26842406
Orthopedics. 2015 Mar;38(3 Suppl):S40-5
pubmed: 25826631
J Bone Joint Surg Br. 2012 Nov;94(11 Suppl A):47-51
pubmed: 23118380
J Arthroplasty. 2020 Mar;35(3):774-778
pubmed: 31685395
J Arthroplasty. 2015 Dec;30(12):2296-8
pubmed: 26145189
Bone Joint J. 2017 Jan;99-B(1 Supple A):31-36
pubmed: 28042116
J Arthroplasty. 2018 Aug;33(8):2535-2540
pubmed: 29729934
Clin Orthop Relat Res. 2012 Aug;470(8):2220-6
pubmed: 22528378
NCHS Data Brief. 2015 Nov;(219):1-8
pubmed: 26633046
Acta Orthop. 2008 Feb;79(1):141-7
pubmed: 18283586
J Knee Surg. 2013 Apr;26(2):89-94
pubmed: 23504647
Clin Orthop Relat Res. 2018 Oct;476(10):1964-1969
pubmed: 30794240
J Orthop. 2018 Mar 17;15(2):379-383
pubmed: 29881158
Int Wound J. 2017 Jun;14(3):529-536
pubmed: 27397553
J Bone Joint Surg Am. 2020 Nov 4;102(21):1874-1882
pubmed: 32769807
Prim Care. 2016 Mar;43(1):121-35, ix
pubmed: 26896205
J Arthroplasty. 2010 Aug;25(5):671-9.e1
pubmed: 20378307
J Orthop. 2014 Sep 11;11(4):166-9
pubmed: 25561750
J Arthroplasty. 2009 Aug;24(5):698-704
pubmed: 18555653
J Arthroplasty. 2016 Sep;31(9 Suppl):162-5
pubmed: 27133929
Clin Orthop Relat Res. 2013 Oct;471(10):3358-66
pubmed: 23670675

Auteurs

Matthias Luger (M)

Department for Orthopedics and Traumatology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Krankenhausstrasse 9, 4020 Linz and Altenberger Strasse 69, 4040, Linz, Austria. Matthias.luger@kepleruniklinikum.at.

Rainer Hochgatterer (R)

Department for Orthopedics and Traumatology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Krankenhausstrasse 9, 4020 Linz and Altenberger Strasse 69, 4040, Linz, Austria.

Clemens Schopper (C)

Department for Orthopedics and Traumatology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Krankenhausstrasse 9, 4020 Linz and Altenberger Strasse 69, 4040, Linz, Austria.

Lorenz Pisecky (L)

Department for Orthopedics and Traumatology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Krankenhausstrasse 9, 4020 Linz and Altenberger Strasse 69, 4040, Linz, Austria.

Jakob Allerstorfer (J)

Department for Orthopedics and Traumatology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Krankenhausstrasse 9, 4020 Linz and Altenberger Strasse 69, 4040, Linz, Austria.

Antonio Klasan (A)

Department for Orthopedics and Traumatology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Krankenhausstrasse 9, 4020 Linz and Altenberger Strasse 69, 4040, Linz, Austria.

Tobias Gotterbarm (T)

Department for Orthopedics and Traumatology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Krankenhausstrasse 9, 4020 Linz and Altenberger Strasse 69, 4040, Linz, Austria.

Bernhard Schauer (B)

Department for Orthopedics and Traumatology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Krankenhausstrasse 9, 4020 Linz and Altenberger Strasse 69, 4040, Linz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH